Subcutaneous injection of mRNA vaccines against severe acute respiratory syndrome coronavirus 2: an option for severe bleeding disorders or anticoagulated patients?

Autor: Karer M; Department of Clinical Pharmacology., Stiasny K; Center for Virology, Medical University of Vienna, Vienna, Austria., Zeitlinger M; Department of Clinical Pharmacology., Jilma B; Department of Clinical Pharmacology.
Jazyk: angličtina
Zdroj: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis [Blood Coagul Fibrinolysis] 2021 Sep 01; Vol. 32 (6), pp. 423-424.
DOI: 10.1097/MBC.0000000000001048
Databáze: MEDLINE